Hospital Acquisition Costs for Breakthrough-Designated Devices Awarded Supplemental Medicare Reimbursement
This cross-sectional study compares manufacturer-reported and actual hospital acquisition costs for breakthrough-designated devices awarded supplemental Medicare reimbursement.
Authors
- Sanket S. Dhruva (ORCID: https://orcid.org/0000-0003-0674-2032)
- Vinay K. Rathi (ORCID: https://orcid.org/0000-0002-9763-9075)
- James Francis Burke (ORCID: https://orcid.org/0000-0002-2296-1588)
- Joseph S. Ross (ORCID: https://orcid.org/0000-0002-9218-3320)
- Lorenz Roth (ORCID: https://orcid.org/0000-0003-0554-4691)
- Kushal T. Kadakia (ORCID: https://orcid.org/0000-0002-9539-7682)
- Osman Moneer (ORCID: https://orcid.org/0000-0003-3191-8028)
Institutions
- Yale New Haven Hospital (US)
- University of California, San Francisco (US)
- Yale University (US)
- Massachusetts General Hospital (US)
- Yale New Haven Health System (US)
- The Ohio State University (US)
- Stanford University (US)
Publication Details
- Journal
- JAMA Health Forum
- Published
- 2025-11-26
- DOI
- https://doi.org/10.1001/jamahealthforum.2025.5183
- Primary Topic
- Health Systems, Economic Evaluations, Quality of Life
- Type
- article
- Field-Weighted Citation Impact
- 0.00